NTRA

Natera
NTRA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$22.58B
EV
$21.78B
Shares Outstanding
139.66M
Beta
1.73

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$191.51
P/E 2025E
-
P/Revenue 2025E
11.47x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Natera, Inc.

gainify
NTRA

Natera, Inc.

NTRA

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier sc...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Chapman, Steven

Employees

4,429

IPO Date

2015-07-01

Headquarters

13011 McCallen Pass, Building A, Suite 100, Austin, Texas, 78753, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.